Workflow guide · Daily publishing
How Biotech Writers Build a Daily News Briefing
Turn a noisy news stream into a concise daily product readers can scan and trust.
The situation
When this workflow becomes useful
A writer or small editorial team must publish a morning or end-of-day biotech briefing across hundreds of possible company updates.
Best fit
Independent writers, newsletter teams, financial media creators, podcasters, and editors covering biotechnology and pharmaceutical companies.
The challenge
Why the obvious approach breaks down
Speed creates pressure to repeat press-release language, while broad coverage creates pressure to include too much. Readers need selection, context, and source clarity.
How to think about the task
The reasoning behind the workflow
A daily newsletter earns attention by selecting and explaining, not by reproducing the feed. Readers need the material new fact, the company and program context, a primary-source path, and a clear distinction between reported information and editorial interpretation.
A fixed editorial process allows a small publication to be fast without letting promotional language or duplicate syndication determine the issue.
Define the publication’s materiality rule
Specify which clinical, regulatory, financing, transaction, and strategic events qualify. The rule should reflect the audience rather than the number of available headlines.
Collapse duplicates around the primary event
Several publishers may repeat the same company release. Treat them as one event, verify the primary source, and write the new fact in original language rather than amplifying repeated summaries.
Maintain a follow-up queue
Breaking items often leave questions about full data, filings, regulatory detail, or management plans. Carry those questions forward so the publication develops stories instead of discarding them after one issue.
Illustrative example
Illustrative six-item morning edition
Twenty-eight overnight links collapse into nine underlying events. Six meet the publication threshold. Each receives a ticker, program, event type, two-sentence explanation, and source link; two are marked for later follow-up.
The issue is shorter than the raw feed and more valuable because selection and context have already been performed for the reader.
Questions to answer before making a decision
- What is the material new fact?
- Is the primary source available?
- What context does this audience need?
- Which unresolved question deserves follow-up?
The workflow
A repeatable way to do the work
- 01
Define the publication window, audience, and event types that qualify for inclusion.
- 02
Group duplicate coverage around the primary source and identify the material new fact.
- 03
Prioritize clinical, regulatory, financing, and transaction events by likely reader impact.
- 04
Add ticker, program, stage, and one sentence of context to each selected item.
- 05
Use a fixed editorial cutoff and maintain a follow-up queue for developing stories.
Monitoring checklist
Signals to keep visible
Common mistakes
- Publishing duplicate versions of the same announcement
- Copying promotional language without context
- Mixing breaking news with analysis without labeling
Output and outcome
What good looks like
Deliverable
A source-linked briefing organized by event importance, with a short context line and clear distinction between fact and interpretation.
Practical outcome
The publication becomes easier to produce consistently and more useful than an undifferentiated list of biotech headlines.
Where BioPharmSignal fits
Reduce the collection work around the decision.
Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.
Frequently asked questions
Who is this workflow for?
It is designed for biotech newsletter writers and adjacent biotech research users who need a repeatable, source-linked way to complete this task.
What should this workflow produce?
A source-linked briefing organized by event importance, with a short context line and clear distinction between fact and interpretation.
What is the practical benefit?
The publication becomes easier to produce consistently and more useful than an undifferentiated list of biotech headlines.
Related workflows